BioSpace News Archive

Astrotech Corporation [NASDAQ: ASTC] announced that the BreathTest-1000™ lung disease screening device that is under development detects a known metabolite that is associated with lung diseases at very low parts per billion (ppb) concentrations. On March 25, the Company announced that it is working on developing the BreathTest-1000™ to detect volatile organic compound metabolites present in lung diseases such as the Coron

Vycor Medical, Inc. (Vycor) (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, reported financial results for the year ended December 31, 2019. Highlights The Vycor Medical division recorded revenue of $1,300,000 from the sale of its products for the year ended December 31, 2019, a decrease of $11,000 (or 1%) over 2018. The US continued to experience growth (increase of 28%), primarily as a result o

Evofem Biosciences, Inc. (NASDAQ: EVFM), a clinical-stage biopharmaceutical company, announced today that Chief Executive Officer Saundra Pelletier will present an overview of the Company and business updates at the upcoming Solebury Trout Virtual Investor Conference.

Canton & Company, a leading healthcare growth and innovation services firm, announced it has joined the Industry Relations Council of the American Academy of Home Care Medicine.

Phunware, Inc., a fully-integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands worldwide, announced it has launched a National Ventilator Registry.

The rapid spread of COVID-19 has put the healthcare industry under tremendous strain as it struggles to provide care for affected patients while facing a staggering shortage of personal protective equipment (PPE) and life-saving medical devices

Guangzhou XlifeSciences, a partner of GenScript ProBio (GenScript’s CDMO segment) announced that the early phase clinical trial of TAEST16001 project has been started. GenScript ProBio extends congratulations on this. This clinical trial project is China’s first TCR-T project targeted at solid tumor therapy, marking a milesto

The NiSource Charitable Foundation, the charitable foundation supported by NiSource Inc., announced that it has committed to $1 million in donations to provide coronavirus relief support across the company’s seven-state service territory.

People infected with COVID-19 diagnosed in the last 24 hours can call 1-877-536-6837 to participate in clinical research aimed to stop the progression of the disease.

Pfizer Inc. (NYSE: PFE) today announced the completion of a $1.25 billion ten-year “sustainability” bond paying interest semi-annually of 2.625 percent and maturing April 1, 2030.